|本期目录/Table of Contents|

[1]郑泓明,陈英敏,杨阳.早期肾癌血清胱抑素C的改变及对肾脏功能评估的临床意义[J].福建医科大学学报,2020,54(04):225-229.
 ZHENG Hongming,CHEN Yingmin,YANG Yang.Changes of Serum Cystatin C in Early Renal Carcinoma and Its Clinical Significance in Renal Function Evaluation[J].Journal of Fujian Medical University,2020,54(04):225-229.
点击复制

早期肾癌血清胱抑素C的改变及对肾脏功能评估的临床意义(PDF)
分享到:

《福建医科大学学报》[ISSN:1672-4194/CN:35-1192/R]

卷:
第54卷
期数:
2020年04期
页码:
225-229
栏目:
临床研究
出版日期:
2020-09-10

文章信息/Info

Title:
Changes of Serum Cystatin C in Early Renal Carcinoma and Its Clinical Significance in Renal Function Evaluation
文章编号:
1672-4194(2020)04-0225-05
作者:
郑泓明 1 陈英敏 2 杨阳 1
1.河北医科大学第二医院 核医学科,石家庄050061; 2.河北省人民医院 医学影像科,石家庄050051
Author(s):
ZHENG Hongming1 CHEN Yingmin2 YANG Yang1
1.Department of Nuclear Medicine, The Affiliated Second Hospital of HebeiMedical University, Shijiazhuang 050061, China; 2.Department of Radiology, Hebei Provincial Hospital, Shijiazhuang 050051, China
关键词:
肾肿瘤 腺癌 透明细胞 肾疾病 同位素 肾动脉/放射摄影术 西司他汀类 肾小球滤过率
Keywords:
kidney neoplasms adenocarcinoma clear cell kidney diseases isotopes renal artery/ radiography cystatins glomerular filtration rate
分类号:
R730.261; R737.11
DOI:
-
文献标志码:
A
摘要:
目的研究早期肾癌患者血清胱抑素C的改变及对肾脏功能评估的临床意义。方法回顾性分析50例已手术治疗的非老年肾透明细胞癌患者,术前 99mTc-DTPA肾动态显像测定肾小球滤过率,通过血清胱抑素C进行肾功能估值。根据肿瘤分期、病理结果、术中所见和尿常规潜血等临床情况分组,分析早期肾癌血清胱抑素C的变化及其对肾功能评估的临床意义。结果非老年早期肾透明细胞癌患者TNM分期为T1bN0M0期( P=0.046)、术中见肿瘤突出于肾脏表面生长并与周围组织粘连(P=0.015)、尿常规中发现潜血( P=0.000)时,术前血清胱抑素C升高。通过血清胱抑素C估计肾功能与核素肾动态显像测定值呈相关关系(r=0.305),但估值偏低。结论T1bN0M0期的早期肾透明细胞癌患者、肿瘤突出肾表与周围组织粘连、尿中出现潜血时,血清胱抑素C升高。患者肾功能正常时,血清胱抑素C升高可能与早期肾癌生长的侵袭性有关。由于血清胱抑素C升高受多种因素影响,术前必须结合肾动态显像评估肾脏功能。
Abstract:
ObjectiveTo study the changes of serum cystatin C in patients with early renal carcinoma and its clinical significance in renal function evaluation.MethodsRetrospective analysis was performed on 50 cases of non elderly patients with renal clear cell carcinoma who had received surgical treatment, preoperative 99mTc DTPA renal dynamic imaging was employed to measure radionuclide glomerular filtration rate(rGFR), serum cystatin C was used to estimate renal function(eGFR).The patients were grouped according to clinical characteristics such as tumor stage, pathological results, intraoperative findings and urine occult blood to analyze the changes of serum cystatin C in early renal carcinoma and its clinical significance in the evaluation of renal function.ResultsThe serum cystatin C was increased in the patients whose TNM stage was T1bN0M0(P=0.046), tumors was protruded from the renal surface and adhered to the surrounding tissues(P=0.015), and urine occult blood was positive(P=0.000).The eGFR value for evaluation of renal function by serum cystatin C was lower while it had a weak correlation with rGFR(r=0.305)measured by radionuclide renal dynamic imaging.ConclusionThe serum cystatin C was increased in patients with early T1bN0M0 stage of renal clear cell carcinoma or whose tumor was protruded from the renal surface and adhered to the surrounding tissues, or urine occult blood was positive.When the patients had normal renal function, elevation in serum cystatin C may be associated with the aggressive growth of early renal carcinoma.Since cystatin C can be affected by many factors, preoperative renal function must be evaluated in combination with renal dynamic imaging.

参考文献/References:

[1]郭军. 从新版肾癌诊治看mRCC诊疗策略[J]. 浙江医学,2016,38(15):1221-1222.
[2]Thomas W F, Paul K, Navdeep T. Cystatin C as a biomarker for estimating glomerular filtration rate[J]. Epidemiology and Prevention,2015,24(3):295-300.
[3]Ye X S, Liu X, Song D,et al. Estimating glomerular filtration rate by serum creatinine or/and cystatin C equations: An analysis of multi-centre Chinese subjects[J]. Nephrology,2016,21(5):372-378.
[4]Launay-Vacher V, Janus N, Deray G. Renal insufficiency and cancer treatments[J]. ESMO Open,2016,1(4):91.
[5]Astor B C,Shaikh S,Chaudhry M. Associations of endogenous markers of kidney function with outcomes: more and less than glomerular filtration rate[J].Curr Opin Nephrol Hypertens,2013,22(3):331-335.
[6]Ayesha Q,Tariq M A,Asma H,et al. Comparison of renal function assessment by cystatin c and creatinine based equations for e-GFR in type 2 diabetics in different stages of albuminuria[J]. Pak Armed Forces Med J, 2017,67(5):746-752.
[7]Colantonio L D,Tanner R M,Warnock D G,et al. The role of cystatin-C in the confirmation of reduced glomerular filtration rate among the oldest old[J]. Archives of Medical Science,2016,12(1):55-67.
[8]Abrahamson M,Alvarez-Fernandez M,Nathanson C M. Cystatins[J]. Biochem Soc Symp,2003,70:179-199.
[9]Guo S J,Xue Y F,He Q M,et al. Preoperative serum cystatin-C as a potential biomarker for prognosis of renal cell carcinoma[J]. PLoS One,2017,12(6):e0178823.)
[10]Guo K B,Chen Q H,He X B,et al. Expression and significance of Cystatin-C in clear cell renal cell carcinoma[J]. Biomed & Pharmacother,2018,107:1237-1245.
[11]王岩,宋华,林晏滨,等. 临床分期T1b期肾细胞癌的病理学特点分析[J]. 中华泌尿外科杂志,2016,37(1):26-29.
[12]Wang W J, Wang X H, Wang Y W,et al. A novel highly frequent single-nucleotide polymorphism site of Catherine 23 in clear cell renal carcinoma with sarcomatoid differentiation based on whole exams sequencing[J]. Oncology Rep,2020,44(2):735-746.
[13]Escudier B,Porta C,Schmidinger M,et al. Renal cell carcinoma:ESMO clinical practice guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol,2019,30(5):706-720.
[14]Zahran A,El-Husseini A,Shoker A. Can cystatin C replace creatinine to estimate glomerular filtration rate A literature review[J]. Am J Nephrol,2007,27(2):197-205.

相似文献/References:

[1]郑 珂,刘从容,陈余朋.宫颈原位腺癌的临床病理及免疫组织化学研究[J].福建医科大学学报,2014,48(05):295.
 ZHENG Ke,LIU Congrong,CHEN Yupeng.Clinicopathologicobservation and ImmunohistochemicalStudy of Cervical Adenocarcinoma in Situ[J].Journal of Fujian Medical University,2014,48(04):295.
[2]陈 新,叶兴安,李仔峰,等.肝细胞核因子在卵巢透明细胞癌中的表达及其意义[J].福建医科大学学报,2014,48(05):299.
 CHEN Xin,YE Xingan,LI Zaifeng,et al.The Expression and Significance of HNF-1β in Ovarian Clear Cell Carcinoma[J].Journal of Fujian Medical University,2014,48(04):299.
[3]黄海鹏,付伟金,韦康来,等.MEKK3在肾透明细胞癌中的表达和临床价值[J].福建医科大学学报,2018,52(05):316.
 HUANG Haipeng,FU Weijin,WEI Kanglai,et al.The Expression and Clinical Significance of MEKK3 in Clear Renal Cell Carcinoma[J].Journal of Fujian Medical University,2018,52(04):316.
[4]曾赛凡,王雪丹,陈余朋,等.4种不同破红液对血性胸水富集瘤细胞效果的研究[J].福建医科大学学报,2019,53(04):281.
 ZENG Saifan,WANG Xuedan,CHEN Yupeng,et al.Effects of Different Red Blood Cell Lysis Buffers in Enrichment Tumor Cell of Hemorrhagic Pleural Effusion[J].Journal of Fujian Medical University,2019,53(04):281.
[5]叶婧璇,杨军.阑尾杯状细胞腺癌3例临床病理分析[J].福建医科大学学报,2020,54(04):274.
 YE JingXuan,YANG Jun.Appendiceal Goblet Cell Adenocarcinoma: a clinicopathological analysis of three cases[J].Journal of Fujian Medical University,2020,54(04):274.

备注/Memo

备注/Memo:
收稿日期: 2019-09-25
基金项目: 河北省2017年度医学科学研究重点课题计划(20170112) 作者简介: 郑泓明,女,副主任医师. Email: hongming_zheng @163.com
更新日期/Last Update: 2020-10-15